LYNX-1: A Phase 3 Study of 0.75% Phentolamine Ophthalmic Solution in Subjects with Dim Light Vision Disturbances

Study limitation reported by the research below: “The paper's publication date (September 2026) is recent; this is a newly published Phase 3 trial and independent replication is not yet available.”